Heart valve repair

BioStable Science & Engineering Announces Initial Closing of Series C Equity Round

Retrieved on: 
Tuesday, February 25, 2020
Biotechnology, Surgery, Medical devices, Health, Cardiology, Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Aortic valve repair, Aortic valve, Heart valve repair, Valve replacement, Mitral valve annuloplasty, Heart valve, Aortic insufficiency, Orlando Health Ventures, Rex Health Ventures, BioStable Science & Engineering

BioStable Science & Engineering, a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, announced today the initial closing of its Series C equity financing.

Key Points: 
  • BioStable Science & Engineering, a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, announced today the initial closing of its Series C equity financing.
  • Lead investors Rex Health Ventures and Orlando Health Ventures were joined by Longmeadow Health Care Partners, Sant Health Ventures, Solas BioVentures, and other prior investors in the round.
  • John Wheeler, President and CEO of BioStable Science & Engineering, concluded by saying, Proceeds from the transactions will allow BioStable to expand sales, marketing, and surgeon training efforts and to initiate its post-market registry study of the HAART Aortic Annuloplasty Devices.
  • BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.

Fourth Annual Heart Valve Disease Awareness Day Campaign Kicks Off with The Greater Harlem Chamber of Commerce

Retrieved on: 
Wednesday, February 19, 2020
Cardiac surgery, Medical specialties, Medicine, Clinical medicine, Valvular heart disease, Heart valve repair, Heart valve

WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- This Saturday February 22 marks the fourth annual Heart Valve Disease Awareness Day ("Valve Disease Day"), a day dedicated to spotlighting the importance of detecting and treating heart valve disease.

Key Points: 
  • WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- This Saturday February 22 marks the fourth annual Heart Valve Disease Awareness Day ("Valve Disease Day"), a day dedicated to spotlighting the importance of detecting and treating heart valve disease.
  • Fortunately, heart valve disease can usually be successfully treated with valve repair and replacement in patients of all ages.
  • Participants will include the Heart Valve Disease Awareness Day partners from across the nation, heart valve disease patients and advocates, heart valve disease experts and medical providers, and more.
  • "Although public awareness of heart valve disease is low, the efforts taken by heart valve disease patients, advocates, and the organizations participating in the annual Valve Disease Day are making important strides in educating the public about their risk factors, the importance of listening to their heart, and available treatment options."

Global Heart Valve Repair and Replacement Devices Market 2019-2023 | Evolving Opportunities with Abbott and Boston Scientific Corporation | Technavio

Retrieved on: 
Thursday, February 6, 2020
Health, Medical devices, Cardiology, Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Valve replacement, Heart valve repair, Percutaneous aortic valve replacement, Aortic valve

View the full release here: https://www.businesswire.com/news/home/20200206005605/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200206005605/en/
    Technavio has announced its latest market research report titled global heart valve repair and replacement devices market 2019-2023 (Graphic: Business Wire)
    Read the 127-page report with TOC on Heart Valve Repair and Replacement Devices Market Analysis Report by Product (Heart valve replacement devices and Heart valve repair devices), Surgery (Minimally invasive surgeries, Transcatheter surgeries, and Open surgeries), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2019-2023.
  • In addition, technological advances are anticipated to boost the growth of the heart valve repair and replacement devices market.
  • Technavio has segmented the heart valve repair and replacement devices market based on the product, surgery, and region.
  • Heart Valve Repair and Replacement Devices Product Outlook (Revenue, USD Billion, 2019 - 2023)
    Heart Valve Repair and Replacement Devices Surgery Outlook (Revenue, USD Billion, 2019 - 2023)

Future Neles strengthens its valves service availability with new service centers in Portugal and France

Retrieved on: 
Tuesday, December 17, 2019
Metso, Cardiac surgery, Companies, Valve Corporation, Heart valve repair, Video game companies, Industries

Metso Corporations press release on December 17, 2019 at 1:00 p.m. EET

Key Points: 
  • Metso Corporations press release on December 17, 2019 at 1:00 p.m. EET
    Metsos valve business, future Neles Corporation, will establish two new service centers in Lisbon, Portugal, and in the Mulhouse area, France, to increase its valves service availability and presence close to customers.
  • Service centers offer valve repair services as well as predictive maintenance services, e.g.
  • We have a comprehensive service portfolio, ranging from genuine quality parts to complex shutdown solutions.
  • The service center in Portugal was opened during the third quarter of 2019.

Global Heart Valve Repair and Replacement Devices Market 2019-2023| Evolving Opportunities with Abbott and CryoLife, Inc | Technavio

Retrieved on: 
Tuesday, December 10, 2019
Health, Medical devices, Cardiology, Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Valve replacement, Heart valve repair, Heart valve

View the full release here: https://www.businesswire.com/news/home/20191210005681/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191210005681/en/
    Technavio has announced its latest market research report titled global heart valve repair and replacement devices market 2019-2023 (Graphic: Business Wire)
    Read the 127-page research report with TOC on "Heart Valve Repair and Replacement Devices Market Analysis Report by Product (Heart valve replacement devices and Heart valve repair devices), by Surgery (Minimally invasive surgeries, Transcatheter surgeries, and Open surgeries), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019-2023".
  • Also, technological advances in heart valve repair and replacement devices are anticipated to further boost the growth of the market during the forecast period.
  • They offer heart valve repair and replacement surgeries to repair and replace defective heart valves that are prone to these conditions.
  • Heart Defect Closure Devices Market Global Heart Defect Closure Devices Market by product (LAA closure devices, PFO closure devices, ASD closure devices, and other heart defect closure devices) and geography (Asia, Europe, North America, and ROW).

Minimally Invasive Heart Valve Repair and Replacement Devices Markets, 2023 - Focus on Transcatheter Aortic Valve Replacement (TAVR) Systems and Transcatheter Mitral Valve Repair (TMVRep) Products

Retrieved on: 
Monday, November 4, 2019
Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Percutaneous aortic valve replacement, Aortic valve, Valve replacement, Heart valve repair, Mitral valve repair, Mitral valve replacement, Mitral valve, Heart valve

DUBLIN, Nov. 4, 2019 /PRNewswire/ -- The "Minimally Invasive Heart Valve Repair and Replacement Devices" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 4, 2019 /PRNewswire/ -- The "Minimally Invasive Heart Valve Repair and Replacement Devices" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive medical market and technology report provides an overview and in-depth market analysis of the transcatheter heart valve products used in the treatment of heart valve stenosis, regurgitation, and other valvular disorders.
  • These products include transcatheter aortic valve replacement (TAVR) systems and transcatheter mitral valve repair (TMVRep) products.
  • In 2018, the global market for transcatheter heart valve management products, including TAVR and TMVRep products, totaled an estimated $4.2bn.

Global Minimally Invasive Heart Valve Repair and Replacement Devices Markets, 2018 & 2019-2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 4, 2019
Health, Surgery, Cardiology, Medical devices, Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Percutaneous aortic valve replacement, Aortic valve, Valve replacement, Heart valve repair, Mitral valve repair, Mitral valve replacement, Mitral valve, Heart valve

The "Minimally Invasive Heart Valve Repair and Replacement Devices" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Minimally Invasive Heart Valve Repair and Replacement Devices" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive medical market and technology report provides an overview and in-depth market analysis of the transcatheter heart valve products used in the treatment of heart valve stenosis, regurgitation, and other valvular disorders.
  • These products include transcatheter aortic valve replacement (TAVR) systems and transcatheter mitral valve repair (TMVRep) products.
  • In 2018, the global market for transcatheter heart valve management products, including TAVR and TMVRep products, totaled an estimated $4.2bn.

Global Surgical Heart Valve Management Products Markets Report 2019: Global Sales of these Products Totaled More than $2.0bn in 2018

Retrieved on: 
Wednesday, October 16, 2019
Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Heart valve repair, Valvular heart disease, Aortic valvuloplasty, Regurgitation, Mitral valve annuloplasty, Valve replacement, Heart valve, Tricuspid valve stenosis

DUBLIN, Oct. 16, 2019 /PRNewswire/ -- The "Surgical Heart Valve Management Products" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 16, 2019 /PRNewswire/ -- The "Surgical Heart Valve Management Products" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive medical market and technology report, which covers the US, five major EU markets, Japan, and RoW markets from 2018-23, provides an overview and in-depth market analysis of the surgical heart valve products used in the treatment of heart valve stenosis, regurgitation, and other valvular disorders.
  • These products include surgical heart valve repair (annuloplasty) systems, surgical heart valve replacement products, and percutaneous balloon valvuloplasty (PBV) systems.
  • Global sales of these products totaled more than $2.0bn in 2018, and are expected to experience relatively flat growth over the forecast period, with PBV sales experiencing robust double-digit growth and heart valve repair and replacement product sales declining.

Global Surgical Heart Valve Management Products Markets, 2018 & 2019-2023 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 16, 2019
Health, Surgery, Cardiology, Medical devices, Cardiac surgery, Medicine, Medical specialties, Clinical medicine, Heart valve repair, Valvular heart disease, Aortic valvuloplasty, Regurgitation, Mitral valve annuloplasty, Valve replacement, Heart valve, Tricuspid valve stenosis

The "Surgical Heart Valve Management Products" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Heart Valve Management Products" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive medical market and technology report, which covers the US, five major EU markets, Japan, and RoW markets from 2018-23, provides an overview and in-depth market analysis of the surgical heart valve products used in the treatment of heart valve stenosis, regurgitation, and other valvular disorders.
  • These products include surgical heart valve repair (annuloplasty) systems, surgical heart valve replacement products, and percutaneous balloon valvuloplasty (PBV) systems.
  • Global sales of these products totaled more than $2.0bn in 2018, and are expected to experience relatively flat growth over the forecast period, with PBV sales experiencing robust double-digit growth and heart valve repair and replacement product sales declining.

AWC Frac Valves Acquires NorMak, Expands Footprint and Strengthens Aftermarket Frac Valve Capabilities

Retrieved on: 
Wednesday, September 18, 2019
Utilities, Oil, Gas, Manufacturing, Energy, Other Manufacturing, Cardiac surgery, Plumbing, Heart valve repair, Valve, Heart valve

AWC Frac Valves, Inc. is pleased to announce that it has completed a definitive Asset Purchase Agreement with NorMak Machine and Hydraulic, LLC, a specialty frac valve repair facility in Ft. Collins, Colorado.

Key Points: 
  • AWC Frac Valves, Inc. is pleased to announce that it has completed a definitive Asset Purchase Agreement with NorMak Machine and Hydraulic, LLC, a specialty frac valve repair facility in Ft. Collins, Colorado.
  • AWC is a recognized leader in the design, manufacturing, repair and refurbishment of hydraulic frac valves.
  • AWC plans to integrate NorMaks frac valve repair and machine capabilities into its current portfolio, further strengthening AWC aftermarket frac valve repair operations .
  • AWCs commitment to the highest-level of customer service for the entire lifecycle of a frac valve is a key differentiator.